Teva Investigational Site 12242 — Hazelwood, Missouri

Teva Investigational Site 12242 is a clinical research site located in Hazelwood, Missouri, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 12242 has participated in 1 clinical trials.

Therapeutic areas: Osteoarthritis of the Knee.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hazelwood

Browse all research sites in Missouri · View every site in Hazelwood

• Healthcare Research Network
• Research Site
• Healthcare Research Network-Hazelwood
• Healthcare Research Network - St. Louis
• Healthcare Research Network - Hazelwood MO
• Aptinyx Clinical Site
• HealthCare Research
• Lexicon Investigational Site
• Investigative Site
• Ferguson-Florissant School District
• Novo Nordisk Investigational Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 12242?

Teva Investigational Site 12242 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 12242 conducted?

Teva Investigational Site 12242 has 1 clinical trials on record. Their work covers Osteoarthritis of the Knee.

Is Teva Investigational Site 12242 accredited by Crixeo Clinical Trials?

Teva Investigational Site 12242 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 12242?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.